Summit Therapeutics Inc. Shares Outstanding
Summit Therapeutics Inc. (SMMT) had Shares Outstanding of 793.12 million shares as of 2026-06-30, per its 10-Q filed 2026-07-23.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-07-23
- 2026-06-30: Shares outstanding (split-adjusted) 793.12M shares; Shares authorized (split-adjusted) 1.00B shares.
- 2026-03-31: Shares outstanding (split-adjusted) 776.02M shares; Shares authorized (split-adjusted) 1.00B shares.
- 2025-12-31: Shares outstanding (split-adjusted) 775.37M shares; Shares authorized (split-adjusted) 1.00B shares.
- 2025-09-30: Shares outstanding (split-adjusted) 744.44M shares; Shares authorized (split-adjusted) 1.00B shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 793.12M shares 10-Q · filed 2026-07-23 | 1.00B shares 10-Q · filed 2026-07-23 |
| 2026-03-31 | 776.02M shares 10-Q · filed 2026-04-30 | 1.00B shares 10-Q · filed 2026-04-30 |
| 2025-12-31 | 775.37M shares 10-Q · filed 2026-07-23 | 1.00B shares 10-Q · filed 2026-07-23 |
| 2025-09-30 | 744.44M shares 10-Q · filed 2025-10-20 | 1.00B shares 10-Q · filed 2025-10-20 |
| 2025-06-30 | 742.81M shares 10-Q · filed 2025-08-11 | 1.00B shares 10-Q · filed 2025-08-11 |
| 2025-03-31 | 741.61M shares 10-Q · filed 2025-05-01 | 1.00B shares 10-Q · filed 2025-05-01 |
| 2024-12-31 | 737.63M shares 10-K · filed 2026-02-23 | 1.00B shares 10-K · filed 2026-02-23 |
| 2024-09-30 | 737.09M shares 10-Q · filed 2024-10-30 | 1.00B shares 10-Q · filed 2024-10-30 |
| 2024-06-30 | 724.32M shares 10-Q · filed 2024-08-06 | 1.00B shares 10-Q · filed 2024-08-06 |
| 2024-03-31 | 701.97M shares 10-Q · filed 2024-05-01 | 1.00B shares 10-Q · filed 2024-05-01 |
| 2023-12-31 | 701.66M shares 10-K · filed 2025-02-24 | 1.00B shares 10-K · filed 2025-02-24 |
| 2023-09-30 | 697.85M shares 10-Q · filed 2023-11-07 | 1.00B shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 697.69M shares 10-Q · filed 2023-08-09 | 1.00B shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 697.69M shares 10-Q · filed 2023-05-11 | 1.00B shares 10-Q · filed 2023-05-11 |
| 2023-01-19 | (m) | 1.00B shares 10-K · filed 2026-02-23 |
| 2023-01-18 | (m) | 350.00M shares 10-K · filed 2026-02-23 |
| 2022-12-31 | 211.09M shares 10-K · filed 2024-02-20 | 1.00B shares 10-K · filed 2024-02-20 |
| 2022-09-30 | 201.32M shares 10-Q · filed 2022-11-09 | 350.00M shares 10-Q · filed 2022-11-09 |
| 2022-07-27 | (m) | 350.00M shares 10-K · filed 2025-02-24 |
| 2022-07-26 | (m) | 250.00M shares 10-K · filed 2025-02-24 |
| 2022-06-30 | 98.12M shares 10-Q · filed 2022-08-11 | 250.00M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 98.12M shares 10-Q · filed 2022-05-11 | 250.00M shares 10-Q · filed 2022-05-11 |
| 2021-12-31 | 98.04M shares 10-K · filed 2023-03-09 | 350.00M shares 10-K · filed 2023-03-09 |
| 2021-09-30 | 97.63M shares 10-Q · filed 2021-11-15 | 250.00M shares 10-Q · filed 2021-11-15 |
| 2021-06-30 | 97.35M shares 10-Q · filed 2021-08-12 | 250.00M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 82.92M shares 10-Q · filed 2021-05-17 | 250.00M shares 10-Q · filed 2021-05-17 |
| 2020-12-31 | 82.58M shares 10-K/A · filed 2022-12-21 | 250.00M shares 10-K/A · filed 2022-12-21 |
| 2020-09-30 | 67.23M shares 10-Q · filed 2020-11-16 | 250.00M shares 10-Q · filed 2020-11-16 |
| 2020-09-18 | 67.23M shares 10-K/A · filed 2022-12-21 | (m) |
| 2020-09-17 | 336.16M shares 10-K/A · filed 2022-12-21 | (m) |
| 2020-06-30 | 67.23M shares 8-K · filed 2020-09-29 | 250.00M shares 8-K · filed 2020-09-29 |
| 2019-12-31 | 67.18M shares 10-K · filed 2021-03-31 | 250.00M shares 10-K · filed 2021-03-31 |
| 2019-01-31 | 32.08M shares 8-K · filed 2020-09-29 | 250.00M shares 8-K · filed 2020-09-29 |
| 2018-01-31 | 14.71M shares 8-K · filed 2020-09-29 | 250.00M shares 8-K · filed 2020-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |